Research Blog | Androchem

SNAP-8: Acetyl Octapeptide Wrinkle Research and SNARE Complex Inhibition

SNAP-8 (acetyl octapeptide-3) is a synthetic peptide analogue of the N-terminal fragment of SNAP-25, a component of the SNARE complex regulating neurotransmitter release. Research has characterised its effects on muscle contraction modulation and expression wrinkle formation.

03 Apr 2026 · 6 min read

Small Molecule ERR Mitochondria

SLU-PP-332: ERR Agonist and Exercise Mimetic Research

SLU-PP-332 is a synthetic agonist of the estrogen-related receptor (ERR) family, specifically targeting ERRα and ERRγ. Research has characterised potent exercise-mimetic effects in preclinical models, increasing mitochondrial biogenesis and aerobic capacity.

31 Mar 2026 · 6 min read

Peptides Amylin Metabolic

Cagrilintide: Long-Acting Amylin Analogue for Metabolic Research

Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk, currently in Phase III trials in combination with semaglutide (CagriSema). It represents the leading edge of dual hormone replacement strategies for obesity and metabolic disease.

28 Mar 2026 · 7 min read

PCT SARMs Post-Cycle

SARMs and Post-Cycle Therapy: Research Guide

SARMs suppress endogenous testosterone in a dose-dependent manner. Post-cycle therapy (PCT) research investigates how to restore HPT axis function using SERMs and AIs. This guide covers Arimistane and Enclomiphene.

28 Mar 2026 · 5 min read

Small Molecule Mitochondria Neuroprotection

Methylene Blue: Mitochondrial Electron Carrier and Neuroprotection Research

Methylene blue is among the oldest synthetic drugs with the longest research history of any compound in medicine. Modern research focuses on its role as a mitochondrial electron carrier, neuroprotective agent, and potential intervention in neurodegenerative disease.

25 Mar 2026 · 7 min read

Peptides Recovery BPC-157

Research Peptides for Recovery: BPC-157, TB-500 and MK-677

BPC-157, TB-500, and MK-677 are researched for tissue repair and recovery. This guide covers what the preclinical literature shows and how researchers approach recovery-focused peptide protocols.

24 Mar 2026 · 5 min read

Peptides Mitochondria Metabolic

MOTS-C: Mitochondrial-Derived Peptide and Metabolic Research

MOTS-C is a 16-amino-acid peptide encoded within the 12S rRNA gene of mitochondrial DNA. Research has characterised its roles in metabolic regulation, insulin sensitivity, physical performance, and ageing — making it a key subject in mitochondrial biology research.

22 Mar 2026 · 7 min read

SARMs Bulking Growth

SARMs for Lean Mass: Research Compound Guide

RAD-140, LGD-4033, YK-11, and MK-677 are the compounds most frequently researched for lean mass accumulation. This guide summarises the evidence for each and how researchers approach them.

20 Mar 2026 · 5 min read

Peptides Sleep Neuropeptide

DSIP: Delta Sleep-Inducing Peptide Research Overview

DSIP (delta sleep-inducing peptide) is a neuropeptide originally isolated during natural slow-wave sleep. Research has examined sleep modulation, stress response, and potential applications in pain and withdrawal states.

19 Mar 2026 · 6 min read

Small Molecule NAD+ Metabolic

5-Amino-1MQ: NNMT Inhibitor and NAD+ Metabolism Research

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT, it increases available NAD+ precursors and SAM, with preclinical data showing adipogenesis inhibition and metabolic benefits.

16 Mar 2026 · 6 min read

SARMs Cutting Research Guide

SARMs for Cutting: Research Compound Selection Guide

Several SARM and non-SARM compounds are researched for their effects on body composition during caloric restriction. This guide covers S-4, SR-9009, Cardarine, and S-23 and what the research shows.

16 Mar 2026 · 5 min read

Peptides Lipolysis Growth Hormone

AOD-9604: Lipolytic Growth Hormone Fragment Research

AOD-9604 is a synthetic fragment of the C-terminal region of human growth hormone, specifically developed for its lipolytic activity without GH-like anabolic or hyperglycaemic effects. Phase II and III data from Metabolic Pharmaceuticals provides a substantial human dataset.

13 Mar 2026 · 6 min read